AutoPiX
Imaging for Patient Benefit in Arthritis
- Description
Rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis affect millions of people across Europe. These immune-mediated inflammatory diseases share challenges, such as the need for timely diagnosis at non-specialist institutions, early and targeted intervention, and effective monitoring.
The AutoPiX project aims to address critical unmet medical needs in imaging in rheumatology. These include limited access to specific techniques, such as ultrasound outside reference centres and hospitals, and precision gaps in selecting the most suitable treatments for arthritis. AI-supported imaging biomarkers could enhance precision medicine and early diagnosis and enable accessible narratives for clinicians and patients. A significant commitment of the project is to enhance the sustainability and efficiency of imaging. In the long term, the tools developed in AutoPiX have the potential to benefit patients by providing a more precise diagnosis, personalised treatment paths, and reliable assessments of their response to treatments.
- Coordinator
- Programme
- Horizon Europe & sub-programmes
- Duration
- 60 months (November 2024 - October 2029)
- Project funding
- € 21,167,177.00
- Project partners
- 20
- Project website
- https://autopix-project.eu
